Still the Great Debate – "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
2016 ◽
Vol 5
(4)
◽
pp. 287-288
◽
2014 ◽
Vol 35
(2)
◽
pp. 190-208
◽
1998 ◽
Vol 12
(4)
◽
pp. 27-42
◽
2004 ◽
Vol 26
(1)
◽
pp. 135-154
◽
2011 ◽
Vol 5
(4)
◽
pp. 248-261
◽
2005 ◽
Vol 24
(4)
◽
pp. 443-468
◽
Keyword(s):
Keyword(s):